Incidence ofnormal micturition in myelomeningocele 641 and, perhaps, a few with pure meningoceles rather than myelomeningoceles.
The aetiology of reflux oesophagitis is multifactorial. However, patients do have more frequent reflux episodes and poorer oesophageal acid clearance than normal individuals.' Conventional medical management of oesophagitis in childhood is based on positioning and the use of pharmacological agents including H2 receptor antagonist treatment. Although the usual clinical outcome is effective resolution of symptoms, a proportion of patients with severe oesophagitis fail to respond. Omeprazole as an alternative treatment to H2 receptor antagonists has been extensively reported in adults with ulcerative oesophagitis and peptic ulcer disease,2 but not in children.
Case report A 7 year old boy presented with vomiting associated with postprandial colicky abdominal pain and a weight loss of 4 kg in the preceding six weeks. There was a history of effortless vomiting from birth, which had not previously been investigated. Despite this, growth parameters were appropriate for age: weight 23 5 kg (50th centile), height 119-5 cm (50th centile), and clinical examination was unremarkable but for borborygmi and non-specific abdominal discomfort.
A blood film suggested a mild iron deficiency anaemia with a haemoglobin concentration of 108 g/l, mean corpuscular volume 68 fl (normal range 7-95) and mean corpuscular haemoglobin 23 pg (25-30). Abdominal ultrasound and a barium meal and follow through were normal. Liver function tests, serum electrolyte concentrations, amylase and lipase, and urine and faeces microscopy and culture were also normal. Oesophageal manometry was not performed.
OESOPHAGEAL PH PROFILE
Oesophageal pH was evaluated using a pH sensitive antimony electrode introduced via the nares, and positioned 4 cm above the lower oesophageal sphincter under fluoroscopic control. Normal activity was allowed for the period of study (24 hours), and data were recorded on a solid state recorder and analysed using a computer programme (Grant Instruments (Cambridge) Ltd, Squirrel Meter/logger).
When compared with normal data taken from 
Discussion
We have documented ulcerative oesophagitis in a 7 year old boy with significant gastrooesophageal reflux. Treatment with an H2 receptor antagonist in combination with a promotility agent and mucosal protective agent for eight weeks failed to produce any improvement. The hydrogen-potassium ATPase proton pump inhibitor, omeprazole, produced symptomatic relief within three days and effective resolution of the oesophageal lesion after eight weeks of treatment. While there is no published experience of omeprazole use in children, it is the treatment of choice for severe oesophageal ulcerative disease in adults, and is more effective in treating reflux oesophagitis than H2 receptor antagonist therapy.4 It has been used safely at doses in excess of 60 mg/day for three years or more in patients with Zollinger-Ellison syndrome.5
Long term treatment using omeprazole is uncharted territory. While there will always be a place for surgery in severe gastro-oesophageal reflux disease, with or without oesophagitis or stricture,6 we suggest that omeprazole should be considered as alternative treatment for children with ulcerative oesophagitis resistant to traditional therapy. 
